Song Paul Y.'s Form 4 filing
NKGen Biotech, Inc. (NKGN) · filed Dec 5, 2023
- Accession no.
- 0001209191-23-057370
- Filed
- Dec 5, 2023
- Trade date
- Dec 4-5, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $849.95. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Song Paul Y.CIK 0001991119 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2023 | Common Stock | PPurchaseAcquired | +162.78 | $3.07 | +$499.73 | 170,864.06 | Direct | |
| Dec 5, 2023 | Common Stock | PPurchaseAcquired | +105.17 | $3.33 | +$350.22 | 170,969.23 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.